Open AccessEarly measurement of IL-10 predicts the outcomes of patients with acute respiratory distress syndrome receiving extracorporeal membrane oxygenation
Author(s) -
Chia Hsiung Liu,
ShuennWen Kuo,
Wen Je Ko,
Pi Ru Tsai,
Shu Wei Wu,
Chien Heng Lai,
Hsiu-Po Wang,
YihSharng Chen,
Pei Lung Chen,
Tze Tze Liu,
ShengJean Huang,
TzuuShuh Jou
Publication year - 2017
Publication title -
scientific reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.24
H-Index - 213
ISSN - 2045-2322
DOI - 10.1038/s41598-017-01225-1
Subject(s) - extracorporeal membrane oxygenation , acute respiratory distress , medicine , respiratory distress , extracorporeal , oxygenation , respiratory system , intensive care medicine , cardiology , anesthesia , lung
Patients diagnosed with acute respiratory distress syndrome are generally severely distressed and associated with high morbidity and mortality despite aggressive treatments such as extracorporeal membrane oxygenation (ECMO) support. To identify potential biomarker of predicting value for appropriate use of this intensive care resource, plasma interleukin-10 along with relevant inflammatory cytokines and immune cell populations were examined during the early and subsequent disease courses of 51 critically ill patients who received ECMO support. High interleukin-10 levels at the time of ECMO installation and during the first 6 hours after ECMO support of these patients stand as a promising biomarker associated with grave prognosis. The initial interleukin-10 level is correlated to other conventional risk evaluation scores as a predictive factor for survival, and furthermore, elevated interleukin-10 levels are also related to a delayed recovery of certain immune cell populations such as CD14 + CD16 + , CD14 + TLR4 + monocytes, and T regulator cells. Genetically, high interleukin-10 is associated to two polymorphic nucleotides (−592 C and −819 C) at the interleukin-10 gene promoter area. Our finding provides prognostic and mechanistic information on the outcome of severely respiratory distressed patients, and potentially paves the strategy to develop new therapeutic modality based on the principles of precision medicine.